News
SBFMW
0.0540
0.00%
0.0000
Sunshine Biopharma Expands Oncology Support Portfolio With Generic Zofran Launch In Canada
NASDAQ · 2d ago
Sunshine Biopharma, Inc. (SBFM) Upgraded to Buy: Here's What You Should Know
NASDAQ · 2d ago
Sunshine Biopharma launches generic Zofran in Canada
TipRanks · 2d ago
Sunshine Biopharma Launches Generic Ondansetron Tablets In Canada
NASDAQ · 2d ago
Sunshine Biopharma Launches Generic Ondansetron Tablets Of 4mg And 8mg In Canadian Market
Benzinga · 2d ago
Weekly Report: what happened at SBFM last week (0914-0918)?
Weekly Report · 6d ago
Sunshine Biopharma CEO Authorizes Potential Reverse Stock Split
TipRanks · 09/16 20:33
Sunshine Biopharma Says CEO Steve Slilaty, Holder Of About 97% Of Voting Power, Approved Reverse Stock Split Of Up To 1-For-20 By Written Consent
Benzinga · 09/16 20:17
Sunshine Biopharma advances lead Coronavirus drug candidate
TipRanks · 09/16 13:15
EXCLUSIVE: Sunshine Biopharma Advances 'Differentiated Antiviral Candidate' to IND-Enabling Studies
Benzinga · 09/16 12:31
Weekly Report: what happened at SBFM last week (0907-0911)?
Weekly Report · 09/14 09:08
Sunshine Biopharma Adjusts Series B Warrant Exercise Price
TipRanks · 09/11 21:27
Weekly Report: what happened at SBFM last week (0831-0904)?
Weekly Report · 09/07 09:08
Sunshine Biopharma announces Health Canada approval for atenolol
TipRanks · 08/31 13:25
Sunshine Biopharma Announces Approval Of Atenolol Tablets Of 25mg, 50mg And 100mg For Canadian Market
Benzinga · 08/31 13:03
Weekly Report: what happened at SBFM last week (0824-0828)?
Weekly Report · 08/31 09:09
Sunshine Biopharma Announces Upcoming Board Leadership Change
TipRanks · 08/28 20:58
Sunshine Biopharma files to sell 24.48M shares of common stock
TipRanks · 08/28 20:20
Sunshine Biopharma provides update, outlines plans for oncology project
TipRanks · 08/26 13:35
Sunshine Biopharma Announces Updates On Its K1.1 mRNA Tumor Suppressor; Outlines Plans For Program
Benzinga · 08/26 13:03
More
Webull provides a variety of real-time SBFMW stock news. You can receive the latest news about Sunshine Biopharma Inc through multiple platforms. This information may help you make smarter investment decisions.
About SBFMW
Sunshine Biopharma, Inc. is a Canada-based pharmaceutical company. The Company offers and researches life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has over 32 additional generic prescription drugs. In addition, the Company is conducting a proprietary drug development program which consists of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for treatment of SARS Coronavirus infections. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). It also operates two wholly owned subsidiaries: NoraPharma Inc., which has a portfolio of pharmaceutical products consisting of approximately 61 generic prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells non-prescription over-the-counter (OTC) products.